Efficacy and Safety of HLD200, Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder

Objective: Evening-dosed HLD200 is a delayed-release and extended-release methylphenidate (DR/ER-MPH) formulation consisting of uniform, dual-layered microbeads with an inner drug-loaded core. DR/ER-MPH is designed to delay the initial release of drug by 8–10 hours, and thereafter, provide a control...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Child Adolesc Psychopharmacol
Glavni autori: Pliszka, Steven R., Wilens, Timothy E., Bostrom, Samantha, Arnold, Valerie K., Marraffino, Andrea, Cutler, Andrew J., López, Frank A., DeSousa, Norberto J., Sallee, Floyd R., Incledon, Bev, Newcorn, Jeffrey H.
Format: Artigo
Jezik:Inglês
Izdano: Mary Ann Liebert, Inc. 2017
Teme:
Original Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5567875/
https://ncbi.nlm.nih.gov/pubmed/29172680
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/cap.2017.0084
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items